eng Science and Education Publishing International Journal of Celiac Disease 2334-3486 2016-05-28 4 2 38 39 10.12691/ijcd-4-2-7 IJCD2016427 article Aaron Lerner aaronlerner1948@gmail.com 1 B. Rappaport School of Medicine, Technion-Israel Institute of Technology, Haifa, Israel Several strategies have been considered for enzymatic detoxification of dietary gluten and to reduce immunogenisity of gliadin peptides. An enzymatic therapy using enterically coated tablets containing caricain (Gluteguard), originated from a papaya, on celiac disease patients challenged with gluten was reported. Glut guard was able to protect these patients from adverse symptoms being induced by gluten challenge. The advantages of the fruit originated preparation are: it does not contain living microbes or bacterial purified or engineered products. It can be considered as a preventive therapy and further step in the future therapeutical strategy race for the celiac affected population benefits. http://pubs.sciepub.com/ijcd/4/2/7/ijcd-4-2-7.pdf celiac disease enzyme supplementation gluten gluten free diet microbial transglutaminase therapy